APA (7th ed.) Citation

SL, H., DA, S., ML, R., M, H., DA, S., JR, G., . . . BL, O. (2025). 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists. Anaesthesia and intensive care, 53(5), 300. https://doi.org/10.1177/0310057X251355288

Chicago Style (17th ed.) Citation

SL, Hocking, et al. "2025 ADS/ANZCA/GESA/NACOS Clinical Practice Recommendations on the Peri-procedural Use of GLP-1/GIP Receptor Agonists." Anaesthesia and Intensive Care 53, no. 5 (2025): 300. https://doi.org/10.1177/0310057X251355288.

MLA (9th ed.) Citation

SL, Hocking, et al. "2025 ADS/ANZCA/GESA/NACOS Clinical Practice Recommendations on the Peri-procedural Use of GLP-1/GIP Receptor Agonists." Anaesthesia and Intensive Care, vol. 53, no. 5, 2025, p. 300, https://doi.org/10.1177/0310057X251355288.